Skip to main content

Table 2 Hemodynamic indices

From: Type 2 diabetes compromises the value of non-invasively measured augmentation index in predicting the severity of coronary artery disease: a hospital-based observational study

  Total
(n = 197)
Non-diabetic
(n = 113)
Diabetic
(n = 84)
p-value
SBP(mmHg) 130.1 ± 17.3 127.8 ± 17.5 133.2 ± 16.6 0.037*
DBP(mmHg) 74.9 ± 11.1 74.8 ± 10.9 75.0 ± 11.5 0.884
CASP(mmHg) 120.3 ± 16.6 118.1 ± 16.5 123.1 ± 16.5 0.044*
MAP(mmHg) 91.9 ± 12.1 91.3 ± 12.8 92.8 ± 11.2 0.387
AP(mmHg) 11.8 ± 7.5 11.9 ± 7.3 11.7 ± 7.9 0.840
Central PP(mmHg) 45.4 ± 13.0 43.5 ± 11.9 48.1 ± 13.9 0.130
Brachial PP(mmHg) 55.2 ± 14.0 53.2 ± 13.2 58.1 ± 14.5 0.130
PR(bpm) 67.7 ± 10.1 67.5 ± 10.3 67.8 ± 9.8 0.750
AIx(%) 77.8 ± 14.5 77.0 ± 14.0 79.0 ± 15.0 0.372
AIx@75(%) 74.9 ± 14.2 74.0 ± 14.3 76.1 ± 13.9 0.317
PRT(ms) 114.5 ± 27.0 116.1 ± 28.1 112.5 ± 25.4 0.374
  1. *p value for comparison between the non-diabetic and diabetic groups; p < 0.05 indicates statistical significance. SBP systolic blood pressure, DBP diastolic blood pressure, MAP mean arterial pressure, PP pulse pressure, PR pulse rate, CASP central aortic systolic pressure, AP augmentation pressure, PRT peak relative time